The Human Papillomavirus (HPV) Transmission Pilot Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

137 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-10-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This transmission pilot study is a prospective study to determine feasibility of enrolling female partners into an international transmission study. Companion study to MCC-13930.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilots of Self-Collection for HPV DNA Detection

NCT00342511

HPV

COMPLETED

Natural History of HPV Infection in Men: The HIM Study

NCT00786760

Human Papillomavirus

COMPLETED

Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer

NCT02809352

HPV Infection

COMPLETED

Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients

NCT02401867

Uterine Cervical Neoplasms Sexually Transmitted Diseases

COMPLETED

Video-Assisted Counseling for HPV Vaccination

NCT03510091

Human Papillomavirus Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We planned to enroll 150 female sexual partners, 75 per year for 2 years, of male study participants in the HPV Infection in Men (HIM) Study. The enrollment period is from June 2006 through May 2008 and participants will be followed through May 2010. At all study visits participants will undergo interviews, a physical exam and laboratory analysis for HPV for a total of 5 clinical visits scheduled every 6 months over 2 years of follow-up. In addition, at each study visit, participants will provide blood for HPV antibody analyses. At enrollment, visit 3 and visit 5 a Pap smear test will be done. At the enrollment visit, study participants will complete a questionnaire designed to assess social and behavioral risk factors for the acquisition of HPV. At each subsequent study visit, participants will be asked to provide updated information to assess changes in risk behaviors such as condom use, relations with new partners, and tobacco use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Papillomavirus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Female Partners

Female partners of HIM Study participants

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female partners of HIM Study participants
* report no abnormal Pap smear during the past 6 months;
* have not had a hysterectomy
* have never been diagnosed with genital warts;
* are not pregnant;
* residents of southern Florida;
* are not and have not been enrolled in an HPV vaccine trial;
* willing to comply with scheduled visits every 6 months for 2 years.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes